Lu Jianmin resigned as an executive director of CSPC Pharmaceutical Group Ltd., effective immediately.
Jianmin is stepping down due to his retirement from the board.
CSPC Pharmaceutical executive director retires
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Lu Jianmin resigned as an executive director of CSPC Pharmaceutical Group Ltd., effective immediately.
Jianmin is stepping down due to his retirement from the board.